In conclusion, our study sheds light on the intricate roles of HDAC1 and HDAC2 as tumor suppressors in ALCL development and highlights the therapeutic potential of HDAC inhibitors, such as Entinostat, in this context. Here, HDAC2 is linked to anaplastic large cell lymphoma.